Sutinen J - Search Results

1

First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K, Geerlings SE, Sutinen J, Ristola M, Danner SA, Reiss P. van Vonderen MG, et al. Among authors: sutinen j. AIDS. 2009 Jul 17;23(11):1367-76. doi: 10.1097/QAD.0b013e32832c4947. AIDS. 2009. PMID: 19424051 Clinical Trial.

2

Severe neutropenia during therapy for concurrent primary human immunodeficiency virus and cytomegalovirus infections.

Sutinen J, Ristola M, Suni J, Nuutinen H, Lähdevirta J. Sutinen J, et al. Clin Infect Dis. 1999 Apr;28(4):920-1. doi: 10.1086/517246. Clin Infect Dis. 1999. PMID: 10825068 No abstract available.

3

Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.

Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H. Sutinen J, et al. AIDS. 2002 Nov 8;16(16):2183-93. doi: 10.1097/00002030-200211080-00011. AIDS. 2002. PMID: 12409740

4

Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H. Sutinen J, et al. Antivir Ther. 2003 Jun;8(3):199-207. Antivir Ther. 2003. PMID: 12924536 Clinical Trial.

5

Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy.

Sevastianova K, Sutinen J, Westerbacka J, Ristola M, Yki-Järvinen H. Sevastianova K, et al. Among authors: sutinen j. Antivir Ther. 2005;10(8):925-35. Antivir Ther. 2005. PMID: 16430198

6

Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.

Sutinen J, Walker UA, Sevastianova K, Klinker H, Häkkinen AM, Ristola M, Yki-Järvinen H. Sutinen J, et al. Antivir Ther. 2007;12(1):97-105. Antivir Ther. 2007. PMID: 17503753 Clinical Trial.

7

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.

Blümer RM, van Vonderen MG, Sutinen J, Hassink E, Ackermans M, van Agtmael MA, Yki-Jarvinen H, Danner SA, Reiss P, Sauerwein HP. Blümer RM, et al. Among authors: sutinen j. AIDS. 2008 Jan 11;22(2):227-36. doi: 10.1097/QAD.0b013e3282f33557. AIDS. 2008. PMID: 18097225 Clinical Trial.

8

Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.

Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Järvinen H. Sevastianova K, et al. Among authors: sutinen j. Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E85-91. doi: 10.1152/ajpendo.90224.2008. Epub 2008 Apr 22. Am J Physiol Endocrinol Metab. 2008. PMID: 18430964 Free article.

9

Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.

van Vonderen MG, Blümer RM, Hassink EA, Sutinen J, Ackermans MT, van Agtmael MA, Yki-Jarvinen H, Danner SA, Serlie MJ, Sauerwein HP, Reiss P. van Vonderen MG, et al. Among authors: sutinen j. J Acquir Immune Defic Syndr. 2010 Feb;53(2):186-93. doi: 10.1097/QAI.0b013e3181c190f4. J Acquir Immune Defic Syndr. 2010. PMID: 19898246 Clinical Trial.

10

[HIV--from a lethal disease to a chronic illness].

Sutinen J, Ristola M. Sutinen J, et al. Duodecim. 2012;128(1):37-46. Duodecim. 2012. PMID: 22312826 Review. Finnish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters